Efficacy and Safety of Surinabant Treatment as an Aid to Smoking Cessation (SURSMOKE)

Clinical trial NCT00432575 · COMPLETED

Trial details

NCT number: NCT00432575
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Smoking Cessation

Start date: 2007-01-01
Primary completion: 2008-04-01
Enrollment: 810

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.